AMBALAL SARABHAI ENTERPRISES
Back to Cashflow Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹-18 Cr | ₹8.89 Cr | ₹5.72 Cr | ₹11 Cr | ₹-2.30 Cr |
What is the latest Cash Flow from Operating Activities ratio of AMBALAL SARABHAI ENTERPRISES ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2025 | ₹-18 Cr |
Mar2024 | ₹8.89 Cr |
Mar2023 | ₹5.72 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹-2.30 Cr |
How is Cash Flow from Operating Activities of AMBALAL SARABHAI ENTERPRISES Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2025 | ₹-18 Cr | Negative | |
Mar2024 | ₹8.89 Cr | 55.23 | |
Mar2023 | ₹5.72 Cr | -50.10 | |
Mar2022 | ₹11 Cr | Positive | |
Mar2021 | ₹-2.30 Cr | - |
Compare Cash Flow from Operating Activities of peers of AMBALAL SARABHAI ENTERPRISES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
AMBALAL SARABHAI ENTERPRISES | ₹265.0 Cr | -2.7% | -3.2% | -49.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,712.0 Cr | -1.2% | 1.3% | 5.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,623.0 Cr | -2% | 1.3% | 45.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,285.0 Cr | 1.4% | 11.9% | 15.7% | Stock Analytics | |
CIPLA | ₹119,010.0 Cr | -0.6% | -2% | -1.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,118.0 Cr | -1.2% | -6.7% | -8.4% | Stock Analytics |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
AMBALAL SARABHAI ENTERPRISES | -2.7% |
-3.2% |
-49.4% |
SENSEX | 0.1% |
1% |
2.6% |
You may also like the below Video Courses